Successful Dartmouth TB Vaccine Moves Forward After Phase 2 Trial

Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine from a three-year trial in Tanzania were announced by investigators at Dartmouth’s Geisel School of Medicine and published in the journal Vaccine.
Source: News at Dartmouth Medical School - Category: Hospital Management Authors: Tags: News Press Release Research Tanzania tubercolosis Source Type: news